Iron off the tee as Takeda rolls out Rienso in EU
This article was originally published in Scrip
Executive Summary
Takeda has launched Rienso (ferumoxytol), a new option for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD) in the UK, after having been granted marketing authorization by the European Commission in June. This is the start of the product’s European roll out.